8-K: Definitive Healthcare Refinances Debt with $175 Million Term Loan and $50 Million Revolving Credit Facility

Definitive Healthcare Corp. secures a new credit agreement amendment, refinancing existing debt with a $175 million term loan and a $50 million revolving credit facility.

Summary

• Definitive Healthcare Holdings, LLC, an indirect subsidiary of Definitive Healthcare Corp., entered into an amendment to its credit agreement on January 16, 2025.
• The amendment provides for a $175 million term loan facility and a $50 million revolving credit facility.
• The proceeds were used to repay the remaining indebtedness under the existing credit agreement and to pay related fees and expenses.
• The loans under both facilities mature on January 16, 2030.
• The facilities are guaranteed by DHH's wholly-owned domestic restricted subsidiaries and AIDH Buyer, LLC, and are secured by substantially all of DHH's assets and the assets of the guarantors.
• The term facility is subject to amortization of principal, payable in quarterly installments commencing on the last day of the first full fiscal quarter after the closing date, equal to 5.0% of the original principal amount of the term loans for each of the five years after the Initial Amortization Date.
• The remaining initial aggregate advances under the Term Facility are payable at the maturity of the Term Facility.
• Interest rates are based on either ABR or Term SOFR plus an applicable margin, subject to step-ups based on the total net leverage ratio.
• DHH will also pay an unused commitment fee on the undrawn commitments under the Revolving Credit Facility.
• DHH and its restricted subsidiaries are subject to customary affirmative, negative, and financial covenants.

Sentiment

Score: 7

Explanation: The document is a standard financial announcement about debt refinancing, which is generally viewed as neutral to slightly positive. The refinancing extends the debt maturity, which is a positive sign for the company's financial stability.

Positives

• The refinancing extends the maturity of the debt to January 16, 2030.
• The agreement provides access to a $50 million revolving credit facility for ongoing needs.

Risks

• The interest rates are subject to step-ups based on the total net leverage ratio, which could increase borrowing costs.
• DHH and its subsidiaries are subject to customary covenants and events of default, which could restrict their operations.

Future Outlook

The document does not contain specific forward-looking statements beyond the maturity date of the facilities.

Industry Context

This announcement reflects a common financial strategy for companies to optimize their capital structure and extend debt maturities, providing greater financial flexibility.

Comparison to Industry Standards

• The interest rate margins of 2.00% to 2.50% for Term SOFR borrowings are within the typical range for leveraged loans of this size and risk profile.
• The amortization schedule of 5.0% per year for the term loan is a standard feature in leveraged loan agreements.
• The covenants are described as customary, suggesting they align with market standards for similar credit facilities.

Stakeholder Impact

• Shareholders: The refinancing provides greater financial stability and flexibility, which could be viewed positively.
• Creditors: The new credit agreement establishes the terms for repayment of the debt.
• Employees: The refinancing supports the company's ongoing operations, which helps ensure job security.

Key Dates